Obelis gained experience as regulatory partner in Horizon 2020 Funded Projects.
GLAM answers the Societal Challenge "Health, demographic change and well-being", aiming to fund research that will have an impact on society, improve the quality of life of European citizens of all ages, maintain the economic sustainability of health and care systems and promote innovation through private and public sectors.
Glam meets a real need and urgency to have new diagnostic devices that provide diagnosis, prognosis, and monitoring data faster and with exquisite ultra-sensitivity on time to take the appropriate decisions to improve personalized diagnosis and therapy.
GLAM project fully accomplishes its objective to provide an innovative device to fulfill these requirements using soluble biomarkers for personalized diagnosis and therapy monitoring.
Specifically we designed and developed a new diagnostic tool to detect biomarkers from biofluids obtained in a non-invasive manner, specifically focusing to urine and to genitourinary cancers, to help oncologist to take better treatment decisions, approaching personalized medicine.
GLAM developed an integrated device based on novel label-free photonic biosensors with ultra-sensitivity, simplicity of use, portability, multiplexing and low cost.
Importantly the GLAM unique technology makes the device also usable with other biofluids and might also be used to help physicians with another biomarker driven.
- Program H2020-EU.3.1.3. - Treating and managing disease
- Topic PHC-10-2014 - Development of new diagnostic tools and technologies: in vitro devices, assays and platforms
- Call for proposal H2020-PHC-2014-two-stage
Find the latest information on the GLAM Project website!
Stay up-to-date with the Horizon 2020 updates. Sign up for our newsletter!